HK1080484B - Polymorph b of a known thiophenecarboxylic acid dodecahydrocyclopenta(a)phenanthrenyl ester - Google Patents

Polymorph b of a known thiophenecarboxylic acid dodecahydrocyclopenta(a)phenanthrenyl ester Download PDF

Info

Publication number
HK1080484B
HK1080484B HK06100247.5A HK06100247A HK1080484B HK 1080484 B HK1080484 B HK 1080484B HK 06100247 A HK06100247 A HK 06100247A HK 1080484 B HK1080484 B HK 1080484B
Authority
HK
Hong Kong
Prior art keywords
compound
formula
crystal form
inflammatory
treatment
Prior art date
Application number
HK06100247.5A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1080484A1 (en
Inventor
Guido Jordine
Michael Mutz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1080484A1 publication Critical patent/HK1080484A1/en
Publication of HK1080484B publication Critical patent/HK1080484B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
HK06100247.5A 2002-07-29 2003-07-28 Polymorph b of a known thiophenecarboxylic acid dodecahydrocyclopenta(a)phenanthrenyl ester HK1080484B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0217504.0A GB0217504D0 (en) 2002-07-29 2002-07-29 Organic compounds
GB0217504.0 2002-07-29
PCT/EP2003/008314 WO2004013156A1 (en) 2002-07-29 2003-07-28 Polymorphis of a known thiophenecarboxylic acid dodecahydrocyclopenta (a) phenanthrenyl ester

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK06114234.1A Division HK1095333A (en) 2002-07-29 2006-01-05 Polymorphs of a known thiophenecarboxylic acid dodecahydrocyclopenta[a]phenanthrenyl ester

Related Child Applications (1)

Application Number Title Priority Date Filing Date
HK06114234.1A Addition HK1095333A (en) 2002-07-29 2006-01-05 Polymorphs of a known thiophenecarboxylic acid dodecahydrocyclopenta[a]phenanthrenyl ester

Publications (2)

Publication Number Publication Date
HK1080484A1 HK1080484A1 (en) 2006-04-28
HK1080484B true HK1080484B (en) 2007-08-03

Family

ID=9941275

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06100247.5A HK1080484B (en) 2002-07-29 2003-07-28 Polymorph b of a known thiophenecarboxylic acid dodecahydrocyclopenta(a)phenanthrenyl ester

Country Status (30)

Country Link
US (1) US7683048B2 (enExample)
EP (2) EP1554303B1 (enExample)
JP (1) JP2006501207A (enExample)
KR (1) KR100688371B1 (enExample)
CN (1) CN1305892C (enExample)
AR (1) AR040692A1 (enExample)
AT (1) ATE349459T1 (enExample)
AU (1) AU2003251651B2 (enExample)
BR (1) BR0313044A (enExample)
CA (1) CA2493330C (enExample)
CY (1) CY1106406T1 (enExample)
DE (1) DE60310747T2 (enExample)
DK (1) DK1554303T3 (enExample)
EC (1) ECSP055579A (enExample)
ES (1) ES2279970T3 (enExample)
GB (1) GB0217504D0 (enExample)
HK (1) HK1080484B (enExample)
IL (2) IL166287A0 (enExample)
MX (1) MXPA05001173A (enExample)
MY (1) MY136407A (enExample)
NO (1) NO20050806L (enExample)
NZ (2) NZ549713A (enExample)
PE (1) PE20040722A1 (enExample)
PL (1) PL209409B1 (enExample)
PT (1) PT1554303E (enExample)
RU (2) RU2348646C1 (enExample)
SI (1) SI1554303T1 (enExample)
TW (1) TWI309164B (enExample)
WO (1) WO2004013156A1 (enExample)
ZA (1) ZA200500370B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2417826A1 (en) 2000-08-05 2002-02-14 Glaxo Group Limited 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
AR033290A1 (es) 2001-04-30 2003-12-10 Glaxo Group Ltd Derivados antiinflamatorios de androstano
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0523654D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
GB0523656D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
GB0603783D0 (en) * 2006-02-24 2006-04-05 Novartis Ag Organic compounds
CN103463084A (zh) * 2008-03-14 2013-12-25 大塚制药株式会社 制剂组合物在制备治疗以mmp-2及/或mmp-9为起因的肺气肿的药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU550939A1 (ru) * 1975-05-19 1994-07-15 Институт химии древесины АН ЛатвССР 1,2,3,4,4а,4в,5,6,10,10а -декагидро -6- хлорацетоксиметил -1,4а-диметил -7- (1-метилэтил) -1- фенантренкарбоновая кислота или ее соли
JPH08291073A (ja) * 1995-04-22 1996-11-05 Kissei Pharmaceut Co Ltd 医薬品組成物及びその製造方法
GB0015876D0 (en) * 2000-06-28 2000-08-23 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
EP1554303B1 (en) 2006-12-27
CY1106406T1 (el) 2011-10-12
NZ537868A (en) 2006-11-30
DE60310747D1 (en) 2007-02-08
US7683048B2 (en) 2010-03-23
PE20040722A1 (es) 2004-11-29
DK1554303T3 (da) 2007-04-30
ECSP055579A (es) 2005-04-18
TWI309164B (en) 2009-05-01
EP1554303A1 (en) 2005-07-20
HK1080484A1 (en) 2006-04-28
GB0217504D0 (en) 2002-09-04
EP1676854A1 (en) 2006-07-05
MXPA05001173A (es) 2005-05-16
PL209409B1 (pl) 2011-08-31
IL184848A0 (en) 2007-12-03
NO20050806L (no) 2005-02-15
NZ549713A (en) 2008-04-30
MY136407A (en) 2008-09-30
AR040692A1 (es) 2005-04-13
AU2003251651A1 (en) 2004-02-23
RU2348646C1 (ru) 2009-03-10
CN1305892C (zh) 2007-03-21
PL373140A1 (en) 2005-08-22
CA2493330A1 (en) 2004-02-12
IL166287A0 (en) 2006-01-15
BR0313044A (pt) 2005-06-14
PT1554303E (pt) 2007-03-30
US20060166954A1 (en) 2006-07-27
JP2006501207A (ja) 2006-01-12
ATE349459T1 (de) 2007-01-15
RU2007143025A (ru) 2009-01-20
KR100688371B1 (ko) 2007-03-02
ZA200500370B (en) 2006-07-26
KR20050033632A (ko) 2005-04-12
RU2005105688A (ru) 2005-10-10
AU2003251651B2 (en) 2007-07-12
WO2004013156A1 (en) 2004-02-12
ES2279970T3 (es) 2007-09-01
SI1554303T1 (sl) 2007-06-30
RU2330043C2 (ru) 2008-07-27
CN1671731A (zh) 2005-09-21
CA2493330C (en) 2011-08-23
DE60310747T2 (de) 2007-10-11
TW200401633A (en) 2004-02-01

Similar Documents

Publication Publication Date Title
US6921757B2 (en) Organic compounds
US20120108555A1 (en) Mixtures or Organic Compounds for the Treatment of Airway Diseases
EP1554303B1 (en) Polymorph b of a known thiophenecarboxylic acid dodecahydrocyclopenta[a]phenanthrenyl ester
EP2044025B1 (en) Quinolinone derivatives and their pharmaceutical compositions
US20100010039A1 (en) Polymorphic crystal form of a indan-2-ylamino-hydroxyethyl-quinolinone maleate derivative as beta-adrenoceptor agonist
HK1095333A (en) Polymorphs of a known thiophenecarboxylic acid dodecahydrocyclopenta[a]phenanthrenyl ester
AU2007202962A1 (en) Polymorphis of a known thiophenecarboxylic acid dodecahydrocyclopenta (A) phenanthrenyl ester
EP1900737A1 (en) Polymorph of (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide
EP1878722A1 (en) Quinolinone derivatives and their pharmaceutical compositions
HK1127597B (en) Quinolinone derivatives and their pharmaceutical compositions

Legal Events

Date Code Title Description
AM Amended specification (according sect 146 of patent law)

Free format text: AMEND JOURNAL DATED 3.8.2007 TO [54] POLYMORPH B OF A KNOWN THIOPHENECARBOXYLIC ACID DODECAHYDROCYCLOPENTA(A)PHENANTHRENYL ESTER

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110728